Immunological effects of a novel RNA-based adjuvant in liver cancer patients (Q39198568)

9 September 2017

title

Immunological effects of a novel RNA-based adjuvant in liver cancer patients (English)

1 reference

9 September 2017

1 reference

1 reference

7

1 reference

9 September 2017

Annacarmen Petrizzo

2

0 references

Maria Tagliamonte

object named as

Maria Tagliamonte

series ordinal

3

0 references

Maria Lina Tornesello

object named as

Maria Lina Tornesello

series ordinal

5

0 references

Regina Heidenreich

series ordinal

4

object named as

Regina Heidenreich

1 reference

9 September 2017

6

Franco M Buonaguro

1 reference

9 September 2017

Luisa Circelli

1

1 reference

9 September 2017

publication date

10 November 2016

1 reference

Cancer Immunology, Immunotherapy

9 September 2017

published in

1 reference

9 September 2017

volume

66

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

103-112

1 reference

Cancer immunotherapy comes of age

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Trial watch: Dendritic cell-based anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Trial Watch: Adoptive cell transfer for oncological indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Trial Watch: Peptide-based anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Vaccine Adjuvants: from 1920 to 2015 and Beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Beyond antigens and adjuvants: formulating future vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Innate immune detection of microbial nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Short communication: limited induction of IL-10 in PBMCs from HIV-infected subjects treated with HIV-VLPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Systems Biology Approach for Cancer Vaccine Development and Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Developments in cancer vaccines for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Cytokines as a link between innate and adaptive antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Human memory T cells: generation, compartmentalization and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

Regulation of effector and memory T-cell functions by type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-016-1923-5

10.1007/S00262-016-1923-5

21 January 2018

Identifiers

DOI

1 reference

release_b54wvx3nsza2tinnpm5o3ozzg4

9 September 2017

Fatcat ID

0 references

1 reference